Masliah E - Search Results

1

Roshanbin S, Aniszewska A, Gumucio A, Masliah E, Erlandsson A, Bergström J, Ingelsson M, Ekmark-Lewén S. Roshanbin S, et al. Among authors: masliah e. Neurobiol Aging. 2021 May;101:207-220. doi: 10.1016/j.neurobiolaging.2021.01.010. Epub 2021 Jan 28. Neurobiol Aging. 2021. PMID: 33639338 Free PMC article.

2

Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody.

Roshanbin S, Julku U, Xiong M, Eriksson J, Masliah E, Hultqvist G, Bergström J, Ingelsson M, Syvänen S, Sehlin D. Roshanbin S, et al. Among authors: masliah e. Pharmaceutics. 2022 Jul 5;14(7):1412. doi: 10.3390/pharmaceutics14071412. Pharmaceutics. 2022. PMID: 35890306 Free PMC article.

3

A refined concept: α-synuclein dysregulation disease.

Mochizuki H, Choong CJ, Masliah E. Mochizuki H, et al. Among authors: masliah e. Neurochem Int. 2018 Oct;119:84-96. doi: 10.1016/j.neuint.2017.12.011. Epub 2018 Jan 2. Neurochem Int. 2018. PMID: 29305061 Free article. Review.

4

Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy.

Lin S, Leitão ADG, Fang S, Gu Y, Barber S, Gilliard-Telefoni R, Castro A, Sung K, Shen R, Florio JB, Mante ML, Ding J, Spencer B, Masliah E, Rissman RA, Wu C. Lin S, et al. Among authors: masliah e. Neurobiol Dis. 2023 Mar;178:106010. doi: 10.1016/j.nbd.2023.106010. Epub 2023 Jan 23. Neurobiol Dis. 2023. PMID: 36702318 Free PMC article.

5

Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's disease.

Leitão ADG, Ahammad RU, Spencer B, Wu C, Masliah E, Rissman RA. Leitão ADG, et al. Among authors: masliah e. Neurobiol Dis. 2023 Oct 1;186:106285. doi: 10.1016/j.nbd.2023.106285. Epub 2023 Sep 9. Neurobiol Dis. 2023. PMID: 37690676 Free article.

6

alpha-Synuclein is phosphorylated in synucleinopathy lesions.

Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T. Fujiwara H, et al. Among authors: masliah e. Nat Cell Biol. 2002 Feb;4(2):160-4. doi: 10.1038/ncb748. Nat Cell Biol. 2002. PMID: 11813001

7

Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson's disease.

Prymaczok NC, De Francesco PN, Mazzetti S, Humbert-Claude M, Tenenbaum L, Cappelletti G, Masliah E, Perello M, Riek R, Gerez JA. Prymaczok NC, et al. Among authors: masliah e. NPJ Parkinsons Dis. 2024 Jan 6;10(1):10. doi: 10.1038/s41531-023-00618-6. NPJ Parkinsons Dis. 2024. PMID: 38184623 Free PMC article.

8

Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease.

Iba M, Kwon S, Kim C, Szabo M, Horan-Portelance L, Lopez-Ocasio M, Dagur P, Overk C, Rissman RA, Masliah E. Iba M, et al. Among authors: masliah e. J Neuroinflammation. 2024 Apr 15;21(1):93. doi: 10.1186/s12974-024-03087-7. J Neuroinflammation. 2024. PMID: 38622654 Free PMC article.

9

Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.

Dufty BM, Warner LR, Hou ST, Jiang SX, Gomez-Isla T, Leenhouts KM, Oxford JT, Feany MB, Masliah E, Rohn TT. Dufty BM, et al. Among authors: masliah e. Am J Pathol. 2007 May;170(5):1725-38. doi: 10.2353/ajpath.2007.061232. Am J Pathol. 2007. PMID: 17456777 Free PMC article.

10

Transglutaminase 2 exacerbates α-synuclein toxicity in mice and yeast.

Grosso H, Woo JM, Lee KW, Im JY, Masliah E, Junn E, Mouradian MM. Grosso H, et al. Among authors: masliah e. FASEB J. 2014 Oct;28(10):4280-91. doi: 10.1096/fj.14-251413. Epub 2014 Jun 26. FASEB J. 2014. PMID: 24970392 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,059 results

Search Page